Global Lung Cancer Molecular Diagnostics Market Insights, Forecast to 2029
This report presents an overview of global market for Lung Cancer Molecular Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Lung Cancer Molecular Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Lung Cancer Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lung Cancer Molecular Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Lung Cancer Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Lung Cancer Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Foundationmedicine, Roche, Qiagen, Liferiver, Tellgen, Genetech, Gpmedical, Sansure and Amoydx, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Lung Cancer Molecular Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Molecular Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Cancer Molecular Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Lung Cancer Molecular Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Lung Cancer Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lung Cancer Molecular Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Lung Cancer Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Lung Cancer Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Foundationmedicine, Roche, Qiagen, Liferiver, Tellgen, Genetech, Gpmedical, Sansure and Amoydx, etc.
By Company
- Foundationmedicine
- Roche
- Qiagen
- Liferiver
- Tellgen
- Genetech
- Gpmedical
- Sansure
- Amoydx
- Mole
- Annoroad
- PCR
- FISH
- DNA Sequencing
- Gene Chip
- Clinical Diagnosis
- Drug Screening
- Research
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Lung Cancer Molecular Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Molecular Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Cancer Molecular Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Lung Cancer Molecular Diagnostics Market Perspective (2018-2029)
2.2 Global Lung Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Lung Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lung Cancer Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Lung Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Lung Cancer Molecular Diagnostics Market Dynamics
2.3.1 Lung Cancer Molecular Diagnostics Industry Trends
2.3.2 Lung Cancer Molecular Diagnostics Market Drivers
2.3.3 Lung Cancer Molecular Diagnostics Market Challenges
2.3.4 Lung Cancer Molecular Diagnostics Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Lung Cancer Molecular Diagnostics by Players
3.1.1 Global Lung Cancer Molecular Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Lung Cancer Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Lung Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Lung Cancer Molecular Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Lung Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Lung Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Molecular Diagnostics Revenue in 2022
3.5 Global Key Players of Lung Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Lung Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Lung Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LUNG CANCER MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY TYPE
4.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
5 LUNG CANCER MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
5.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Lung Cancer Molecular Diagnostics Market Size (2018-2029)
6.2 North America Lung Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
6.3 North America Lung Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
6.4 North America Lung Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Lung Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Lung Cancer Molecular Diagnostics Market Size (2018-2029)
7.2 Europe Lung Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
7.3 Europe Lung Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
7.4 Europe Lung Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Lung Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Lung Cancer Molecular Diagnostics Market Size (2018-2029)
8.2 China Lung Cancer Molecular Diagnostics Market Size by Type
8.2.1 China Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
8.2.2 China Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
8.2.3 China Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
8.3 China Lung Cancer Molecular Diagnostics Market Size by Application
8.3.1 China Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
8.3.2 China Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
8.3.3 China Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Lung Cancer Molecular Diagnostics Market Size (2018-2029)
9.2 Asia Lung Cancer Molecular Diagnostics Market Size by Type
9.2.1 Asia Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
9.3 Asia Lung Cancer Molecular Diagnostics Market Size by Application
9.3.1 Asia Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
9.4 Asia Lung Cancer Molecular Diagnostics Market Size by Region
9.4.1 Asia Lung Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Lung Cancer Molecular Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Lung Cancer Molecular Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Foundationmedicine
11.1.1 Foundationmedicine Company Details
11.1.2 Foundationmedicine Business Overview
11.1.3 Foundationmedicine Lung Cancer Molecular Diagnostics Introduction
11.1.4 Foundationmedicine Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.1.5 Foundationmedicine Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Lung Cancer Molecular Diagnostics Introduction
11.2.4 Roche Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.2.5 Roche Recent Developments
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Lung Cancer Molecular Diagnostics Introduction
11.3.4 Qiagen Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.3.5 Qiagen Recent Developments
11.4 Liferiver
11.4.1 Liferiver Company Details
11.4.2 Liferiver Business Overview
11.4.3 Liferiver Lung Cancer Molecular Diagnostics Introduction
11.4.4 Liferiver Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.4.5 Liferiver Recent Developments
11.5 Tellgen
11.5.1 Tellgen Company Details
11.5.2 Tellgen Business Overview
11.5.3 Tellgen Lung Cancer Molecular Diagnostics Introduction
11.5.4 Tellgen Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.5.5 Tellgen Recent Developments
11.6 Genetech
11.6.1 Genetech Company Details
11.6.2 Genetech Business Overview
11.6.3 Genetech Lung Cancer Molecular Diagnostics Introduction
11.6.4 Genetech Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.6.5 Genetech Recent Developments
11.7 Gpmedical
11.7.1 Gpmedical Company Details
11.7.2 Gpmedical Business Overview
11.7.3 Gpmedical Lung Cancer Molecular Diagnostics Introduction
11.7.4 Gpmedical Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.7.5 Gpmedical Recent Developments
11.8 Sansure
11.8.1 Sansure Company Details
11.8.2 Sansure Business Overview
11.8.3 Sansure Lung Cancer Molecular Diagnostics Introduction
11.8.4 Sansure Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.8.5 Sansure Recent Developments
11.9 Amoydx
11.9.1 Amoydx Company Details
11.9.2 Amoydx Business Overview
11.9.3 Amoydx Lung Cancer Molecular Diagnostics Introduction
11.9.4 Amoydx Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.9.5 Amoydx Recent Developments
11.10 Mole
11.10.1 Mole Company Details
11.10.2 Mole Business Overview
11.10.3 Mole Lung Cancer Molecular Diagnostics Introduction
11.10.4 Mole Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.10.5 Mole Recent Developments
11.11 Annoroad
11.11.1 Annoroad Company Details
11.11.2 Annoroad Business Overview
11.11.3 Annoroad Lung Cancer Molecular Diagnostics Introduction
11.11.4 Annoroad Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.11.5 Annoroad Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Lung Cancer Molecular Diagnostics Market Perspective (2018-2029)
2.2 Global Lung Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Lung Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lung Cancer Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Lung Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Lung Cancer Molecular Diagnostics Market Dynamics
2.3.1 Lung Cancer Molecular Diagnostics Industry Trends
2.3.2 Lung Cancer Molecular Diagnostics Market Drivers
2.3.3 Lung Cancer Molecular Diagnostics Market Challenges
2.3.4 Lung Cancer Molecular Diagnostics Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Lung Cancer Molecular Diagnostics by Players
3.1.1 Global Lung Cancer Molecular Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Lung Cancer Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Lung Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Lung Cancer Molecular Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Lung Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Lung Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Molecular Diagnostics Revenue in 2022
3.5 Global Key Players of Lung Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Lung Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Lung Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LUNG CANCER MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY TYPE
4.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
5 LUNG CANCER MOLECULAR DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
5.1 Global Lung Cancer Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Lung Cancer Molecular Diagnostics Market Size (2018-2029)
6.2 North America Lung Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
6.3 North America Lung Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
6.4 North America Lung Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Lung Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Lung Cancer Molecular Diagnostics Market Size (2018-2029)
7.2 Europe Lung Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
7.3 Europe Lung Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
7.4 Europe Lung Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Lung Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Lung Cancer Molecular Diagnostics Market Size (2018-2029)
8.2 China Lung Cancer Molecular Diagnostics Market Size by Type
8.2.1 China Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
8.2.2 China Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
8.2.3 China Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
8.3 China Lung Cancer Molecular Diagnostics Market Size by Application
8.3.1 China Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
8.3.2 China Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
8.3.3 China Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Lung Cancer Molecular Diagnostics Market Size (2018-2029)
9.2 Asia Lung Cancer Molecular Diagnostics Market Size by Type
9.2.1 Asia Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
9.3 Asia Lung Cancer Molecular Diagnostics Market Size by Application
9.3.1 Asia Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
9.4 Asia Lung Cancer Molecular Diagnostics Market Size by Region
9.4.1 Asia Lung Cancer Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Lung Cancer Molecular Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Lung Cancer Molecular Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Foundationmedicine
11.1.1 Foundationmedicine Company Details
11.1.2 Foundationmedicine Business Overview
11.1.3 Foundationmedicine Lung Cancer Molecular Diagnostics Introduction
11.1.4 Foundationmedicine Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.1.5 Foundationmedicine Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Lung Cancer Molecular Diagnostics Introduction
11.2.4 Roche Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.2.5 Roche Recent Developments
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Lung Cancer Molecular Diagnostics Introduction
11.3.4 Qiagen Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.3.5 Qiagen Recent Developments
11.4 Liferiver
11.4.1 Liferiver Company Details
11.4.2 Liferiver Business Overview
11.4.3 Liferiver Lung Cancer Molecular Diagnostics Introduction
11.4.4 Liferiver Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.4.5 Liferiver Recent Developments
11.5 Tellgen
11.5.1 Tellgen Company Details
11.5.2 Tellgen Business Overview
11.5.3 Tellgen Lung Cancer Molecular Diagnostics Introduction
11.5.4 Tellgen Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.5.5 Tellgen Recent Developments
11.6 Genetech
11.6.1 Genetech Company Details
11.6.2 Genetech Business Overview
11.6.3 Genetech Lung Cancer Molecular Diagnostics Introduction
11.6.4 Genetech Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.6.5 Genetech Recent Developments
11.7 Gpmedical
11.7.1 Gpmedical Company Details
11.7.2 Gpmedical Business Overview
11.7.3 Gpmedical Lung Cancer Molecular Diagnostics Introduction
11.7.4 Gpmedical Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.7.5 Gpmedical Recent Developments
11.8 Sansure
11.8.1 Sansure Company Details
11.8.2 Sansure Business Overview
11.8.3 Sansure Lung Cancer Molecular Diagnostics Introduction
11.8.4 Sansure Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.8.5 Sansure Recent Developments
11.9 Amoydx
11.9.1 Amoydx Company Details
11.9.2 Amoydx Business Overview
11.9.3 Amoydx Lung Cancer Molecular Diagnostics Introduction
11.9.4 Amoydx Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.9.5 Amoydx Recent Developments
11.10 Mole
11.10.1 Mole Company Details
11.10.2 Mole Business Overview
11.10.3 Mole Lung Cancer Molecular Diagnostics Introduction
11.10.4 Mole Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.10.5 Mole Recent Developments
11.11 Annoroad
11.11.1 Annoroad Company Details
11.11.2 Annoroad Business Overview
11.11.3 Annoroad Lung Cancer Molecular Diagnostics Introduction
11.11.4 Annoroad Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023)
11.11.5 Annoroad Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Lung Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Lung Cancer Molecular Diagnostics Market Share by Region (2018-2023)
Table 10. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Lung Cancer Molecular Diagnostics Market Share by Region (2024-2029)
Table 12. Lung Cancer Molecular Diagnostics Market Trends
Table 13. Lung Cancer Molecular Diagnostics Market Drivers
Table 14. Lung Cancer Molecular Diagnostics Market Challenges
Table 15. Lung Cancer Molecular Diagnostics Market Restraints
Table 16. Global Lung Cancer Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Lung Cancer Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 18. Global Top Lung Cancer Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Molecular Diagnostics as of 2022)
Table 19. Global Lung Cancer Molecular Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Lung Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Lung Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Lung Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Lung Cancer Molecular Diagnostics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2024-2029)
Table 29. Global Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Lung Cancer Molecular Diagnostics Revenue Share by Application (2018-2023)
Table 31. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Lung Cancer Molecular Diagnostics Revenue Share by Application (2024-2029)
Table 33. North America Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Lung Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Lung Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Lung Cancer Molecular Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Lung Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Lung Cancer Molecular Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 65. Foundationmedicine Company Details
Table 66. Foundationmedicine Business Overview
Table 67. Foundationmedicine Lung Cancer Molecular Diagnostics Product
Table 68. Foundationmedicine Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 69. Foundationmedicine Recent Developments
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Lung Cancer Molecular Diagnostics Product
Table 73. Roche Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 74. Roche Recent Developments
Table 75. Qiagen Company Details
Table 76. Qiagen Business Overview
Table 77. Qiagen Lung Cancer Molecular Diagnostics Product
Table 78. Qiagen Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Qiagen Recent Developments
Table 80. Liferiver Company Details
Table 81. Liferiver Business Overview
Table 82. Liferiver Lung Cancer Molecular Diagnostics Product
Table 83. Liferiver Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 84. Liferiver Recent Developments
Table 85. Tellgen Company Details
Table 86. Tellgen Business Overview
Table 87. Tellgen Lung Cancer Molecular Diagnostics Product
Table 88. Tellgen Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 89. Tellgen Recent Developments
Table 90. Genetech Company Details
Table 91. Genetech Business Overview
Table 92. Genetech Lung Cancer Molecular Diagnostics Product
Table 93. Genetech Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 94. Genetech Recent Developments
Table 95. Gpmedical Company Details
Table 96. Gpmedical Business Overview
Table 97. Gpmedical Lung Cancer Molecular Diagnostics Product
Table 98. Gpmedical Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 99. Gpmedical Recent Developments
Table 100. Sansure Company Details
Table 101. Sansure Business Overview
Table 102. Sansure Lung Cancer Molecular Diagnostics Product
Table 103. Sansure Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 104. Sansure Recent Developments
Table 105. Amoydx Company Details
Table 106. Amoydx Business Overview
Table 107. Amoydx Lung Cancer Molecular Diagnostics Product
Table 108. Amoydx Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 109. Amoydx Recent Developments
Table 110. Mole Company Details
Table 111. Mole Business Overview
Table 112. Mole Lung Cancer Molecular Diagnostics Product
Table 113. Mole Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 114. Mole Recent Developments
Table 115. Annoroad Company Details
Table 116. Annoroad Business Overview
Table 117. Annoroad Lung Cancer Molecular Diagnostics Product
Table 118. Annoroad Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 119. Annoroad Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 1. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Lung Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Lung Cancer Molecular Diagnostics Market Share by Region (2018-2023)
Table 10. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Lung Cancer Molecular Diagnostics Market Share by Region (2024-2029)
Table 12. Lung Cancer Molecular Diagnostics Market Trends
Table 13. Lung Cancer Molecular Diagnostics Market Drivers
Table 14. Lung Cancer Molecular Diagnostics Market Challenges
Table 15. Lung Cancer Molecular Diagnostics Market Restraints
Table 16. Global Lung Cancer Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Lung Cancer Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 18. Global Top Lung Cancer Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Molecular Diagnostics as of 2022)
Table 19. Global Lung Cancer Molecular Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Lung Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Lung Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Lung Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Lung Cancer Molecular Diagnostics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 27. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Lung Cancer Molecular Diagnostics Revenue Market Share by Type (2024-2029)
Table 29. Global Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Lung Cancer Molecular Diagnostics Revenue Share by Application (2018-2023)
Table 31. Global Lung Cancer Molecular Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Lung Cancer Molecular Diagnostics Revenue Share by Application (2024-2029)
Table 33. North America Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Lung Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Lung Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Lung Cancer Molecular Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Lung Cancer Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Lung Cancer Molecular Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 65. Foundationmedicine Company Details
Table 66. Foundationmedicine Business Overview
Table 67. Foundationmedicine Lung Cancer Molecular Diagnostics Product
Table 68. Foundationmedicine Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 69. Foundationmedicine Recent Developments
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Lung Cancer Molecular Diagnostics Product
Table 73. Roche Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 74. Roche Recent Developments
Table 75. Qiagen Company Details
Table 76. Qiagen Business Overview
Table 77. Qiagen Lung Cancer Molecular Diagnostics Product
Table 78. Qiagen Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Qiagen Recent Developments
Table 80. Liferiver Company Details
Table 81. Liferiver Business Overview
Table 82. Liferiver Lung Cancer Molecular Diagnostics Product
Table 83. Liferiver Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 84. Liferiver Recent Developments
Table 85. Tellgen Company Details
Table 86. Tellgen Business Overview
Table 87. Tellgen Lung Cancer Molecular Diagnostics Product
Table 88. Tellgen Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 89. Tellgen Recent Developments
Table 90. Genetech Company Details
Table 91. Genetech Business Overview
Table 92. Genetech Lung Cancer Molecular Diagnostics Product
Table 93. Genetech Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 94. Genetech Recent Developments
Table 95. Gpmedical Company Details
Table 96. Gpmedical Business Overview
Table 97. Gpmedical Lung Cancer Molecular Diagnostics Product
Table 98. Gpmedical Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 99. Gpmedical Recent Developments
Table 100. Sansure Company Details
Table 101. Sansure Business Overview
Table 102. Sansure Lung Cancer Molecular Diagnostics Product
Table 103. Sansure Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 104. Sansure Recent Developments
Table 105. Amoydx Company Details
Table 106. Amoydx Business Overview
Table 107. Amoydx Lung Cancer Molecular Diagnostics Product
Table 108. Amoydx Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 109. Amoydx Recent Developments
Table 110. Mole Company Details
Table 111. Mole Business Overview
Table 112. Mole Lung Cancer Molecular Diagnostics Product
Table 113. Mole Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 114. Mole Recent Developments
Table 115. Annoroad Company Details
Table 116. Annoroad Business Overview
Table 117. Annoroad Lung Cancer Molecular Diagnostics Product
Table 118. Annoroad Revenue in Lung Cancer Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 119. Annoroad Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Lung Cancer Molecular Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. PCR Features
Figure 4. FISH Features
Figure 5. DNA Sequencing Features
Figure 6. Gene Chip Features
Figure 7. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Lung Cancer Molecular Diagnostics Market Share by Application: 2022 VS 2029
Figure 9. Clinical Diagnosis Case Studies
Figure 10. Drug Screening Case Studies
Figure 11. Research Case Studies
Figure 12. Lung Cancer Molecular Diagnostics Report Years Considered
Figure 13. Global Lung Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Lung Cancer Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Lung Cancer Molecular Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Lung Cancer Molecular Diagnostics Market Share by Players in 2022
Figure 17. Global Top Lung Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Molecular Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Molecular Diagnostics Revenue in 2022
Figure 19. North America Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 21. North America Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 22. North America Lung Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 23. United States Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Lung Cancer Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 27. Europe Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 28. Europe Lung Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 29. Germany Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Lung Cancer Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 37. China Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 38. Asia Lung Cancer Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 40. Asia Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 41. Asia Lung Cancer Molecular Diagnostics Market Share by Region (2018-2029)
Figure 42. Japan Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 52. Brazil Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Foundationmedicine Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 60. Qiagen Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 61. Liferiver Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 62. Tellgen Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 63. Genetech Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 64. Gpmedical Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 65. Sansure Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 66. Amoydx Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 67. Mole Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 68. Annoroad Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Figure 1. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Lung Cancer Molecular Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. PCR Features
Figure 4. FISH Features
Figure 5. DNA Sequencing Features
Figure 6. Gene Chip Features
Figure 7. Global Lung Cancer Molecular Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Lung Cancer Molecular Diagnostics Market Share by Application: 2022 VS 2029
Figure 9. Clinical Diagnosis Case Studies
Figure 10. Drug Screening Case Studies
Figure 11. Research Case Studies
Figure 12. Lung Cancer Molecular Diagnostics Report Years Considered
Figure 13. Global Lung Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Lung Cancer Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Lung Cancer Molecular Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Lung Cancer Molecular Diagnostics Market Share by Players in 2022
Figure 17. Global Top Lung Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Molecular Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Molecular Diagnostics Revenue in 2022
Figure 19. North America Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 21. North America Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 22. North America Lung Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 23. United States Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Lung Cancer Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 27. Europe Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 28. Europe Lung Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 29. Germany Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Lung Cancer Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 37. China Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 38. Asia Lung Cancer Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 40. Asia Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 41. Asia Lung Cancer Molecular Diagnostics Market Share by Region (2018-2029)
Figure 42. Japan Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Lung Cancer Molecular Diagnostics Market Share by Country (2018-2029)
Figure 52. Brazil Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Lung Cancer Molecular Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Foundationmedicine Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 60. Qiagen Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 61. Liferiver Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 62. Tellgen Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 63. Genetech Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 64. Gpmedical Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 65. Sansure Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 66. Amoydx Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 67. Mole Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 68. Annoroad Revenue Growth Rate in Lung Cancer Molecular Diagnostics Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
